Assessment of response to open-label treatment with varenicline in psychiatric inpatients.

Trial Profile

Assessment of response to open-label treatment with varenicline in psychiatric inpatients.

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 24 Jul 2015

At a glance

  • Drugs Varenicline (Primary)
  • Indications Depression; Smoking withdrawal
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Jul 2015 Last checked against ClinicalTrials.gov record.
    • 27 Sep 2010 Status changed from completed to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 28 May 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top